Cohen Announces More Than $3.1 Million for University Of Tennessee Health Science Center

[MEMPHIS, TN] – Congressman Steve Cohen (TN-09) today announced the U.S. Department of Health and Human Services has awarded the University of Tennessee Health Science Center nine federal grants totaling $3,133,410 for a variety of programs and research projects.

“This significant investment of federal funds will help the UT Health Science Center stay at the forefront of medical research,” said Congressman Cohen.

Today’s announcement includes funding for the following UT Health Science Center programs:

• $1,118,114 in funding from HHS’ Centers for Medicare & Medicaid Services (CMS) for the Health Care Innovation Challenge - Project SAFEMED to help the CMS treat patients and improve medication for a variety of health conditions.

• $375,000 in funding from HHS’ National Heart, Lung, and Blood Institute for research regarding CXCR4 signaling in lung epithelial repair.

• $371,171 in funding from HHS’ National Institute on Alcohol Abuse and Alcoholism for research on the comparison of ethanol actions on slo channels from arteries versus brain.

• $328,125 in funding from HHS’ National Institute of Neurological Disorders and Strokes for research on synaptic transmissions in the basal ganglia

• $315,375 in funding from HHS’ National Institute of Diabetes and Digestive and Kidney Diseases for research on the role of diet and body weight in regards to the modulation of AgRp.

• $300,000 in funding from HHS’ National Institute of Diabetes and Digestive and Kidney Diseases for research on the regulation of neonatal renal hemodynamics.

• $178,125 in funding from HHS’ National Institute on Alcohol Abuse and Alcoholism for research on the fetal cerebrovascular eCB system as a target of maternal alcohol consumption.

• $75,000 in funding from HHS’ National Institute on Drug Abuse for research on the effects on the disposition of caffeine after inhalation.

• $72,500 in funding from HHS’ National Institute of Mental Health for research on the antidepressive effects and gene mechanisms of early-life enriched environments.